Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STERAL study of switching efavirenz to raltegravir in HIV/HCV coinfection
2013-002111-10Phase 4Completed
- Sponsor
- Dr. Juan MacÃas Sánchez
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of raltegravir and efavirenz in steatosis (2 arms), sponsored by Dr. Juan MacÃas Sánchez. Primary endpoint: Controlled attenuation parameter at 48 weeks. Started Jul 2013; status: completed.
02
Drugs
raltegravirefavirenz
03
Conditions
steatosis
Beyond the preview
Go deeper on 2013-002111-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002111-10.